Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Tewari KS, Burger RA, Enserro D. et al.
Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer.

J Clin Oncol 2019;
37 (26) 2317-2328
DOI: 10.1200/JCO.19.01009.

Bibliographische Angaben herunterladen

Aufrufen in: